Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Inovio's DNA-Encoded Monoclonal Antibody (dMAb(TM)) Platform Leaps Forward with First-in-Human Trial 2019-01-07 21:00
China Biologic Reiterates Full Year 2018 Financial Forecast 2019-01-07 21:00
AGC Biologics Announces Change in Executive Leadership 2019-01-07 20:00
Uni-Bio Science's Anti-diabetic Acarbose Oral Tablets BE Study Application Accepted by the National Medical Products Administration 2019-01-05 01:04
China SXT Pharmaceuticals, Inc. Announces Final Closing of Initial Public Offering 2019-01-04 20:30
Alphamab Oncology is Invited to Present at the 37th Annual J.P. Morgan Healthcare Conference 2019-01-04 17:02
Gathering Quality Pharmaceutical Excipients from Around the World, PharmaExcipients China 2019 Helps the Chinese Pharmaceutical Industry Achieve Comprehensive Upgrading 2019-01-04 15:00
Picosun and Nanexa Solidify Their Collaboration in Pharmaceutical ALD 2019-01-04 11:13
Ping An Good Doctor Launches Commercial Operation of One-minute Clinics and Signs Contracts For Nearly 1,000 Units, Serving More Than 3 Million Users 2019-01-04 09:40
OrigiMed Completes Series B Round Focusing on Creating a Comprehensive Precision Medicine Platform for Oncology 2019-01-04 09:30
Charkit Chemical Garners NACD Responsible Distribution Verification For Its Sixth Three-Year Cycle 2019-01-04 07:32
Clarivate Analytics Launches Advanced Predictive Analytics Solution to Help Accelerate Drug Development 2019-01-04 02:04
Dr. Jan M. Lundberg, Former Head of R&D at AstraZeneca and Eli Lilly has Joined Betagenon's Board of Directors 2019-01-03 17:49
ProBioGen's GlymaxX(R) ADCC Enhancement Technology Used by Betta Pharmaceuticals 2019-01-03 17:22
Adlai Nortye Announces Clinical Collaboration with Merck to Evaluate Adlai Nortye's AN0025 (EP4 Antagonist) in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors 2019-01-03 16:00
Gathering Hotspots of the Preparation Industry, In Step with the International Pharmaceutical Trends 2019-01-03 15:00
Sinovant Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference 2019-01-03 09:00
Ascletis' IND Filing for Its Third HCV Drug ASC21 Accepted by NMPA 2019-01-03 08:00
Connect Biopharmaceuticals Completes $55 Million Series B Financing to Accelerate Clinical Development of Novel Immune Modulators 2019-01-03 03:15
China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering 2019-01-03 02:30
1 667 668 669 670 671 964